Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2025-12-25 @ 2:45 AM
NCT ID:
NCT06752733
Eligibility Criteria:
Inclusion Criteria:
* Patients with atrial fibrillation
* Patients with persistent or symptomatic atrial fibrillation who are candidates for electrical cardioversion
* Patients eligible for anticoagulation therapy for thromboembolism prevention before and after the procedure
* Patients who can understand and provide written informed consent
Exclusion Criteria:
* Patients under 18 years of age or over 80 years of age
* Patients who do not consent to participate in the study
* Patients with severe coronary artery stenosis
* Patients with severe hepatic dysfunction
* Patients with severe renal dysfunction
* Patients with severe valvular heart disease
* Patients with a high risk of severe bleeding
* Patients with a history of atrial fibrillation-related catheter ablation or cardiac surgery
* Patients with an expected life expectancy of less than 1 year
* Potentially pregnant individuals
* Patients deemed unsuitable for the study by the investigator
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT06752733
Study Brief:
Protocol Section:
NCT06752733